Showing 1451-1460 of 1635 results for "".
- GenSight Biologics Reports Final REALITY Study Confirms Poor Spontaneous Recovery for LHON Patients with ND4 mutationhttps://modernod.com/news/gensight-biologics-reports-final-reality-study-confirms-poor-spontaneous-recovery-for-lhon-patients-with-nd4-mutation/2478050/GenSight Biologics reported results from the final analysis of the REALITY natural history study, which reaffirm the poor prognosis for the vast majority of Leber Hereditary Optic Neuropathy (LHON) patients with vision loss due to a mutated ND4mitochondrial gene. “The REALITY findings bols
- J&J Eyes Late-Stage Study Start of COVID-19 Vaccine in Septemberhttps://modernod.com/news/jj-eyes-late-stage-study-start-of-covid-19-vaccine-in-september/2478037/Johnson & Johnson disclosed alongside its second-quarter earnings call on Thursday that it hopes to begin a late-stage study of its COVID-19 vaccine candidate Ad26.COV2-S in late September, ahead of its previous schedule. The company is in talks with the US National Institutes of Health to br
- Arctic Vision Announces $32 Million in Series A to Expand and Develop Ophthalmology Pipelinehttps://modernod.com/news/arctic-vision-announces-32-million-in-series-a-to-expand-and-develop-ophthalmology-pipeline/2478009/Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, announced its $32 million Series A financing led by Morningside Ventures, together with its existing investors. Arctic Vision focu
- Kodiak Sciences Announces New Longer-Term Data from Ongoing Phase 1b Study of KSI-301 in Patients With Retinal Diseaseshttps://modernod.com/news/kodiak-sciences-announces-new-longer-term-data-from-ongoing-phase-1b-study-of-ksi-301-in-patients-with-retinal-diseases/2478001/Kodiak Sciences announced promising additional safety, efficacy and durability data from the ongoing phase 1b study of its investigational therapy KSI-301, an intravitreal anti-VEGF antibody biopolymer conjugate, in patients with treatment-naïve wet AMD, diabetic mac
- Novavax Gains $1.6 Billion in Funding for COVID-19 Vaccine Candidatehttps://modernod.com/news/novavax-gains-1-6-billion-in-funding-for-covid-19-vaccine-candidate/2477984/Novavax announced that it has been awarded $1.6 billion by the US government to progress development of NVX CoV2373 and potentially deliver 100 million doses of the COVID-19 vaccine as early as late 2020. NVX‑CoV2373 consists of a stable, prefusion protein made using Novavax’s nanop
- Plex Pharmaceuticals Awarded $1.6 Million in Grant Funding from NIH to Advance Eye Drop Therapy for Cataractshttps://modernod.com/news/plex-pharmaceuticals-awarded-1-6-million-in-grant-funding-from-nih-to-advance-eye-drop-therapy-for-cataracts/2477987/Plex Pharmaceuticals announced that it has been awarded two Small Business Innovation Research grants from the National Institutes of Health (NIH) National Eye Institute: a $1.3 million phase 2 grant (R44EY027236) and a $300,000 phase 1
- Apple Was Already Developing Handwashing Sensing Before COVID-19 Hithttps://modernod.com/news/apple-was-already-developing-handwashing-sensing-before-covid-19-hit/2477981/When Apple vice president of technology Kevin Lynch announced at WWDC last week that Apple Watch would add an automatic handwashing-detection feature in its next update, many people naturally assumed the feature was prompted by the COVID-19 pandemic – a public health emergency that has strongly u
- After Sale of Ellex Medical Lasers, Nova Eye Medical is Formedhttps://modernod.com/news/nova-eye-medical-launches-to-propel-glaucoma-innovation/2477952/Ellex Medical Lasers has completed the sale of its Ellex Lasers & Ultrasound business to Quantel Medical via Lumibird Group SA, and changed its name from Ellex Medical Lasers Limited to Nova Eye Medical Limited. In December 2019, Lumibird Group, the parent company of Quantel Medical, s
- Versant Health Debuts New Eye Care Resource Centerhttps://modernod.com/news/versant-health-debuts-new-eye-care-resource-center/2477925/In celebration of Healthy Vision Month this July, Versant Health has launched a new resource center providing tools that enable people to take command of their vision health. Designated by the National Eye Institute, Healthy Vision Month is dedicated to highlighting the importance of eye h
- NIH Becomes Latest to Halt COVID-19 Trial of Hydroxychloroquinehttps://modernod.com/news/nih-becomes-latest-to-halt-covid-19-trial-of-hydroxychloroquine/2477917/Another clinical trial testing hydroxychloroquine in hospitalized patients with COVID-19 has been stopped, this one by the US National Institutes of Health (NIH). The agency said that the ORCHID study’s data and safety monitoring board found, after having conducted its fourth interim analys